Key points from article :
AVITA Therapeutics has entered a preclinical research collaboration with Houston Methodist Research Institute.
The project seeks to establish proof-of-concept for the development of a novel approach to reverse ageing and rejuvenate skin.
AVITA Therapeutics has also secured an exclusive, worldwide license to this patented technology for skin applications.
"This is another milestone in our commitment to harnessing the promise of regenerative medicine and unlocking the full potential of our technology platform to improve patients’ lives through skin restoration.” - Dr. Mike Perry, CEO
The Houston Methodist team has an RNA technology that reverses ageing of cells.
The research collaboration will explore applications of this RNA technology to rejuvenate skin by reversing ageing mechanisms.
The initial research program is expected to run 18 months.
